Roxana Mehran

154.4k total citations · 44 hit papers
1.3k papers, 76.4k citations indexed

About

Roxana Mehran is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roxana Mehran has authored 1.3k papers receiving a total of 76.4k indexed citations (citations by other indexed papers that have themselves been cited), including 930 papers in Cardiology and Cardiovascular Medicine, 783 papers in Surgery and 388 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roxana Mehran's work include Coronary Interventions and Diagnostics (674 papers), Acute Myocardial Infarction Research (578 papers) and Cardiac Imaging and Diagnostics (376 papers). Roxana Mehran is often cited by papers focused on Coronary Interventions and Diagnostics (674 papers), Acute Myocardial Infarction Research (578 papers) and Cardiac Imaging and Diagnostics (376 papers). Roxana Mehran collaborates with scholars based in United States, Italy and Germany. Roxana Mehran's co-authors include Gregg W. Stone, Alexandra J. Lansky, George Dangas, Martin B. Leon, Gary S. Mintz, Eugenia Nikolsky, Jeffrey W. Moses, Martin Fahy, Donald E. Cutlip and Pascal Vranckx and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Roxana Mehran

1.2k papers receiving 74.2k citations

Hit Papers

Clinical End Points in Coronary Stent Trials 1999 2026 2008 2017 2007 2011 2011 2011 2004 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical End Points in Coronary Stent Trials
    2007 4.2k citations Stephan Windecker, Roxana Mehran et al. Circulation profile →
  2. Standardized Bleeding Definitions for Cardiovascular Clinical Trials
    2011 2.9k citations Roxana Mehran, Adriano Caixeta et al. Circulation profile →
  3. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
    2011 2.4k citations Roxana Mehran et al. Circulation profile →
  4. A Prospective Natural-History Study of Coronary Atherosclerosis
    2011 2.1k citations Gregg W. Stone, Alexandra J. Lansky et al. profile →
  5. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention
    2004 1.6k citations Roxana Mehran, Martin Fahy et al. Journal of the American College of Cardiology profile →
  6. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
    2011 1.5k citations Roxana Mehran et al. Journal of the American College of Cardiology profile →
  7. Bivalirudin during Primary PCI in Acute Myocardial Infarction
    2008 1.2k citations Gregg W. Stone, Bernhard Witzenbichler et al. profile →
  8. Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
    2007 1.2k citations Gregg W. Stone, Ajay J. Kirtane et al. profile →
  9. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
    2016 1.0k citations Christopher B. Granger, Roxana Mehran et al. Journal of the American College of Cardiology profile →
  10. Angiographic Patterns of In-Stent Restenosis
    1999 986 citations Roxana Mehran, George Dangas et al. Circulation profile →
  11. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
    2016 942 citations Roxana Mehran et al. profile →
  12. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
    2011 897 citations Mitchell W. Krucoff, Roxana Mehran et al. European Heart Journal profile →
  13. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
    2016 895 citations Christopher B. Granger, Roxana Mehran et al. Circulation profile →
  14. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary interventionDevelopment and initial validation
    2004 893 citations Roxana Mehran, Martin Fahy et al. Journal of the American College of Cardiology profile →
  15. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
    2016 857 citations Usman Baber, Roxana Mehran et al. profile →
  16. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
    2021 762 citations Birgit Vogel, Yolande Appelman et al. profile →
  17. Contrast-induced nephropathy: Definition, epidemiology, and patients at risk
    2006 655 citations Roxana Mehran et al. profile →
  18. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
    2013 613 citations Gregg W. Stone, Bernhard Witzenbichler et al. profile →
  19. Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes
    2007 604 citations Frederick Feit, Roxana Mehran et al. Journal of the American College of Cardiology profile →
  20. In-Stent Restenosis in the Drug-Eluting Stent Era
    2010 591 citations George Dangas, Adriano Caixeta et al. Journal of the American College of Cardiology profile →
  21. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency
    2000 578 citations Roxana Mehran, George Dangas et al. Journal of the American College of Cardiology profile →
  22. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation
    2005 567 citations Giora Weisz, George Dangas et al. Journal of the American College of Cardiology profile →
  23. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials
    2011 540 citations Mitchell W. Krucoff, Roxana Mehran et al. Journal of the American College of Cardiology profile →
  24. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
    2018 514 citations Roxana Mehran, Gregg W. Stone et al. Circulation profile →
  25. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
    2014 506 citations Roxana Mehran et al. Circulation profile →
  26. Comparison of Propensity Score Methods and Covariate Adjustment
    2017 481 citations Usman Baber, Samantha Sartori et al. Journal of the American College of Cardiology profile →
  27. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary
    2011 469 citations Roxana Mehran et al. Circulation profile →
  28. A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
    2010 444 citations Roxana Mehran, Stuart Pocock et al. Journal of the American College of Cardiology profile →
  29. Safety and Efficacy of Drug-Eluting and Bare Metal Stents
    2009 408 citations Ajay J. Kirtane, Bruce R. Brodie et al. Circulation profile →
  30. Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization
    2013 402 citations Roxana Mehran, Gregg W. Stone et al. Journal of the American College of Cardiology profile →
  31. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
    2014 380 citations Roxana Mehran et al. Journal of the American College of Cardiology profile →
  32. Contrast-Associated Acute Kidney Injury
    2019 363 citations Roxana Mehran, George Dangas et al. profile →
  33. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions
    2015 356 citations Gregg W. Stone, Philippe Généreux et al. Journal of the American College of Cardiology profile →
  34. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
    2017 349 citations Usman Baber, Roxana Mehran et al. Circulation profile →
  35. Ischemic Outcomes After Coronary Intervention of Calcified Vessels in Acute Coronary Syndromes
    2014 338 citations Philippe Généreux, Tullio Palmerini et al. Journal of the American College of Cardiology profile →
  36. Prosthetic Heart Valve Thrombosis
    2016 298 citations George Dangas, Gennaro Giustino et al. Journal of the American College of Cardiology profile →
  37. Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults
    2015 297 citations Usman Baber, Roxana Mehran et al. Journal of the American College of Cardiology profile →
  38. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
    2015 272 citations Philippe Généreux, Gennaro Giustino et al. Journal of the American College of Cardiology profile →
  39. 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
    2017 263 citations Roxana Mehran et al. Journal of the American College of Cardiology profile →
  40. ST-segment elevation myocardial infarction
    2019 234 citations Birgit Vogel, Vijay Kunadian et al. profile →
  41. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
    2020 221 citations Roxana Mehran et al. Circulation profile →
  42. Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention
    2020 204 citations Ajay J. Kirtane, Björn Redfors et al. Journal of the American College of Cardiology profile →
  43. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
    2020 201 citations Roxana Mehran et al. Journal of the American College of Cardiology profile →
  44. Coronary In-Stent Restenosis
    2022 183 citations Gennaro Giustino, Roxana Mehran et al. Journal of the American College of Cardiology profile →

Peers

Roxana Mehran
Gregg W. Stone United States
David R. Holmes United States
Martin B. Leon United States
Alexandra J. Lansky United States
Harvey D. White New Zealand
Philippe Gabríel Steg France
Bernard J. Gersh United States
Antonio Colombo Italy
Christopher B. Granger United States
Eugene Braunwald United States
Gregg W. Stone United States
Roxana Mehran
Citations per year, relative to Roxana Mehran Roxana Mehran (= 1×) peers Gregg W. Stone

Countries citing papers authored by Roxana Mehran

Since Specialization
Citations

This map shows the geographic impact of Roxana Mehran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Mehran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Mehran more than expected).

Fields of papers citing papers by Roxana Mehran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana Mehran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Mehran. The network helps show where Roxana Mehran may publish in the future.

Co-authorship network of co-authors of Roxana Mehran

This figure shows the co-authorship network connecting the top 25 collaborators of Roxana Mehran. A scholar is included among the top collaborators of Roxana Mehran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxana Mehran. Roxana Mehran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fudim, Marat, Renato D. Lópes, Daniel Wojdyla, et al.. (2025). Apixaban Dose in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention. JACC Advances. 4(4). 101665–101665. 1 indexed citations
2.
Occhipinti, Giovanni, Claudio Laudani, Mattía Galli, et al.. (2025). Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis. European Heart Journal. 2 indexed citations
3.
McCarthy, Patrick M., Roxana Mehran, Marc Gerdisch, et al.. (2024). Left atrial appendage exclusion during open cardiac surgery in patients without atrial fibrillation reduces 4-year ischemic stroke and mortality. SHILAP Revista de lepidopterología. 4. 100032–100032.
4.
Hengstenberg, Christian, Martin Unverdorben, Helge Möllmann, et al.. (2024). Risk Factors of Ischemic Stroke in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Implantation from the Randomized ENVISAGE-TAVI AF Trial. The American Journal of Cardiology. 227. 98–104. 1 indexed citations
5.
Wojdyla, Daniel, Alexander C. Fanaroff, Andrzej Budaj, et al.. (2024). Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI. Journal of the American College of Cardiology. 84(10). 875–885. 1 indexed citations
6.
Goel, Ridhima, Samantha Sartori, Birgit Vogel, et al.. (2024). Geographic Mapping of Gender Disparities in Authorship of Cardiovascular Literature. Journal of the American College of Cardiology. 83(24). 2458–2468. 3 indexed citations
7.
Spirito, Alessandro, Michael C. Gao, Samantha Sartori, et al.. (2024). Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians. Catheterization and Cardiovascular Interventions. 103(7). 1079–1087. 2 indexed citations
8.
Farhan, Serdar, Clayton Snyder, Gurpreet Johal, et al.. (2023). Determinants of Seattle Angina Questionnaire in Multivessel Disease Patients Undergoing Percutaneous Coronary Intervention: Insights from a Single-Center Study. Cardiovascular revascularization medicine. 49. 28–33.
9.
Wely, Marleen van, Helmut Gehlmann, Michel Verkroost, et al.. (2023). Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis. International Journal of Cardiology. 394. 131353–131353. 3 indexed citations
10.
Galli, Mattía, Giuseppe Gargiulo, Stefano Benenati, Roxana Mehran, & Dominick J. Angiolillo. (2023). Mortality with bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome. European Heart Journal. 44(Supplement_2). 1 indexed citations
11.
Dziewierz, Artur, Birgit Vogel, Krzysztof Piotr Malinowski, et al.. (2023). Operator-patient sex discordance and periprocedural outcomes of percutaneous coronary intervention (from the ORPKI Polish National Registry). Advances in Interventional Cardiology. 19(2). 113–118. 3 indexed citations
12.
13.
Kalkman, Deborah N., Jolien Neefs, Birgit Vogel, et al.. (2023). Migraine and cardiovascular disease: what cardiologists should know. European Heart Journal. 44(30). 2815–2828. 32 indexed citations
14.
Krucoff, Mitchell W., Davide Cao, & Roxana Mehran. (2022). ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike. EuroIntervention. 18(6). 448–449.
15.
Krittanawong, Chayakrit, Dhruv Mahtta, Bharat Narasimhan, et al.. (2020). Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort. IJC Heart & Vasculature. 30. 100634–100634. 22 indexed citations
16.
Redfors, Björn, Chunhui He, Tullio Palmerini, et al.. (2017). The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery.. PubMed. 29(2). 42–49. 2 indexed citations
17.
Mennuni, Marco, George Dangas, Roxana Mehran, et al.. (2015). Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial.. PubMed. 27(10). 468–73. 6 indexed citations
18.
Herrmann, Joerg, Bernard J. Gersh, Judith Z. Goldfinger, et al.. (2014). Body Mass Index and Acute and Long-Term Outcomes After Acute Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). The American Journal of Cardiology. 114(1). 9–16. 33 indexed citations
19.
Rosner, Gregg, Ajay J. Kirtane, Philippe Généreux, et al.. (2012). Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes. Circulation. 125(21). 2613–2620. 91 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregg W. Stone Breakdown of academic impact, for papers by David R. Holmes Breakdown of academic impact, for papers by Martin B. Leon Breakdown of academic impact, for papers by Alexandra J. Lansky Breakdown of academic impact, for papers by Harvey D. White Breakdown of academic impact, for papers by Philippe Gabríel Steg Breakdown of academic impact, for papers by Bernard J. Gersh Breakdown of academic impact, for papers by Antonio Colombo Breakdown of academic impact, for papers by Christopher B. Granger Breakdown of academic impact, for papers by Eugene Braunwald
Rankless by CCL
2026